JPH08208678A - Substance (srt) existing in plant world has basic structure of life, its characteristic eliminates animal cancer (in vivo) and human cancer (in vitro) and it itself degrades naturally - Google Patents

Substance (srt) existing in plant world has basic structure of life, its characteristic eliminates animal cancer (in vivo) and human cancer (in vitro) and it itself degrades naturally

Info

Publication number
JPH08208678A
JPH08208678A JP7048931A JP4893195A JPH08208678A JP H08208678 A JPH08208678 A JP H08208678A JP 7048931 A JP7048931 A JP 7048931A JP 4893195 A JP4893195 A JP 4893195A JP H08208678 A JPH08208678 A JP H08208678A
Authority
JP
Japan
Prior art keywords
srt
substance
cancer
rabbit
plant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7048931A
Other languages
Japanese (ja)
Inventor
Hidenao Takazawa
秀直 高澤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senka Corp
Original Assignee
Senka Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senka Corp filed Critical Senka Corp
Priority to JP7048931A priority Critical patent/JPH08208678A/en
Publication of JPH08208678A publication Critical patent/JPH08208678A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

PURPOSE: To elucidate basic structure of a life in which a nucleus-like substance/ mitochondria/ribosome in a substance (SRT) derived from a plant are confirmed and specific numbers of main protein components exist in the substance and which has eliminating action on animal cancerous tissue. CONSTITUTION: An extracted solution of a plant is scattered on 10% PDA(potato dextrose agar), incubated in a constant temperature device at 37 deg.C, harvested two weeks after and collected in a screw bottle to give the objective substance (SRT) in which a nucleus-like substance/mitochondria/ribosome in a substance (SRT) derived from a plant are confirmed and six main protein components having 64.47kDa, 51.57kDa, 32.58kDa, 21.50kDa, 17.99kDa and 64.47kDa molecular weight exist in the substance (SRT) and which has pharmacodynamically effective action to permeate cells, destroy and eliminate the cells after administration of SRT in a human cancer (HeLa cell, colon cancer cell) in vitro and to start cavitation after inoculation (intermittent inoculation ten times) to a cancer occurring in the thigh of a rabbit and to eliminate the cancer in an animal experiment in vivo.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】広く植物界に存在している物質(SRT)
が、我々の健康体としての維持管理で様々な薬効作用を
持っていることが分ってきた。今回の発明の目的として
は、この薬理効果をもつ物質(SRT)の蛋白質成分と
小動物をつかった前臨床実験を通して、この物質(SR
T)が持つ生命体としての基本構造の確認とその効能の
特徴づけをして行くことにある。
Substances widely existing in the plant kingdom (SRT)
However, it has been found that our health maintenance has various medicinal effects. The purpose of the present invention is to study the substance (SRT) through preclinical experiments using protein components of this substance (SRT) and small animals.
It is to confirm the basic structure of T) as a living organism and to characterize its efficacy.

【0002】[0002]

【従来の技術】我々が生活して行くうえで、植物は必要
欠くべからざるものであってその用途は多様である。今
回我々が求めるものは、栄養素としてのものではなく薬
効果のあるものに限定している。従来から、植物由来の
ものが飲み薬・貼り薬等々として効果があることは一般
に知られていることである。だだその採取等というと気
候風土に左右されたり特別な環境に依存しなければなら
ないとか、生成過程においても特異なものであった。従
って基礎実験、小動物を使った前臨床実験等を経ないで
直接人体に投与等がなされて来た。我々はこれらを基本
的なものから捉えてかいししはじめた。
2. Description of the Related Art Plants are indispensable for our daily lives, and their uses are diverse. This time, we are limiting what we are looking for to have medicinal effects rather than nutrients. It has been generally known that plant-derived substances are effective as a medicine for medicine, a patch, etc. However, such collection was unique in the process of production, such as being influenced by the climate and having to depend on a special environment. Therefore, it has been directly administered to the human body without undergoing basic experiments and preclinical experiments using small animals. We started to take these things from the basic ones.

【0003】[0003]

【発明が解決しようとする課題】従来の技術の項でも述
べたように、採取方法においても生成方法においても、
あるいは、調製法においてもすべて特異な存在下で行な
われて来たこのような状況を見直し作業工程を簡素化し
効率を上げようとしなければならない。我々が捉えてい
る物質(SRT)はこれらの条件に適合している。
As described in the section of the prior art, in both the sampling method and the generation method,
Alternatively, even in the preparation method, it is necessary to review such a situation, which has been performed in the presence of peculiarity, to simplify the work process and improve the efficiency. The substance we capture (SRT) meets these requirements.

【0004】[0004]

【課題を解決するための手段】それぞれの目的に応じ
て、この物質(SRT)の性格づけ、また大量に集めな
ければ成らない。この物質の培養の基本的操作手順とし
ては、10%PDA(ポテトデオストロース)の寒天培
地上で行う。収集も手作業であるが、効率よく採取出来
る。こうして集めた物質(SRT)も基礎的な実験及び
生体内の実験を行い、蛋白質成分及び動物癌に対する薬
理効果を解折した。
[Means for Solving the Problems] According to each purpose, it is necessary to characterize this substance (SRT) and collect a large amount of it. The basic procedure for culturing this substance is to perform it on an agar medium containing 10% PDA (potato deostrose). Collection is manual, but can be collected efficiently. The substance (SRT) thus collected was also subjected to basic experiments and in vivo experiments, and its pharmacological effect on protein components and animal cancer was solved.

【0005】[0005]

【作用と実施例】本発明の基礎実験と小動物をつかった
前臨床実験の結果を表示し説明を加える。
ACTIONS AND EXAMPLES The results of the basic experiments of the present invention and the preclinical experiments using small animals are displayed and explained.

【0006】[0006]

【第1例】 植物由来物質(SRT)の調製 1)材料 植物抽出液 10%PDA(ポテトデキストロース寒天)、クロラ
ムフェニコール(25mg/L) 2)培養方法と条件 10%PDA上に抽出液0.5ml/Lpを撒く 37℃恒湿器にてインキューベート 2週間後収穫しスクリューボトル(5ml)に集め
る。 3)植物由来物質(SRT)の実験と保存 実験系 4)植物由来物質(SRT)の分析 構造体 膜壁、核様体、ミトコンドリア、リボゾーム 日本医科大学電子顕微鏡施設へ依頼 蛋白質成分の分析 (株)東洋レーヨン基礎医学研究所へ依頼
[First example] Preparation of plant-derived substance (SRT) 1) Material Plant extract 10% PDA (potato dextrose agar), chloramphenicol (25 mg / L) 2) Culture method and conditions Extract on 10% PDA Spread 0.5 ml / Lp Incubate at 37 ° C incubator 2 weeks later and collect in screw bottles (5 ml). 3) Experiments and preservation of plant-derived substances (SRT) 4) Analysis of plant-derived substances (SRT) Structure Membrane wall, nucleoid, mitochondria, ribosome Request to electron microscope facility of Nippon Medical School Analysis of protein components Request to Toyo Rayon Institute of Basic Medicine

【0007】[0007]

【第2例】 植物由来物質(SRT)の試験管内検索 1)HeLa及び大腸癌細胞の培養条件 10%FCS培養液 a)粉末培地:(株)日水製薬のMEM培地 b)カナマイシン:(株)日水製薬の抗性物質 c)炭酸水素ナトリウム:関東化学(株) d)仔牛血清(Fcs):IRVINE社,GIBCO
社 e)再溜水 0.25%Trypsin a)2.5%Trypsin(1:250):IRVI
NE社 2)HeLa及び大腸癌細胞の培養液方法 3)検索 (Assay)
[Second example] In vitro search for plant-derived substance (SRT) 1) Culture conditions for HeLa and colon cancer cells 10% FCS culture medium a) Powder medium: Nissui Pharmaceutical's MEM medium b) Kanamycin: (strain) ) Nissui Pharmaceutical's anti- substance c) Sodium bicarbonate: Kanto Chemical Co., Ltd. d) Calf serum (Fcs): IRVINE, GIBCO
Company e) Redistilled water 0.25% Trypsina a) 2.5% Trypsin (1: 250): IRVI
2) HeLa and colorectal cancer cell culture medium method 3) Search (Assay)

【0008】[0008]

【第3例】植物由来物質(SRT)の動物生体内検索 1)材料及び管理 (株)船橋農場渡来 智先生(元東京医科大学)に依頼 ウサギ:Assay用10羽(2.0kg前後) Vx2継代ウサギ(オリジナル) 2)移植手順 3)Assay [Third example] Animal bio-retrieval of plant-derived substances (SRT) 1) Materials and management Request from Dr. Satoshi Watari (formerly Tokyo Medical University), Funabashi Farm Co., Ltd. Rabbit: 10 for assay (around 2.0 kg) Vx2 Rabbit (original) 2) Transplant procedure 3) Assay

【0009】[0009]

【発明の効果】以上の実験結果を基に請求項を検討する
とこれら生命体としての基本構造を有する物質(SR
T)が動物癌を消滅させることが確認されたことから、
これら発病した動物がもとの生活を営むことも可能であ
ると考えられるれる。
[Effects of the Invention] When the claims are examined on the basis of the above experimental results, substances having the basic structure of these living organisms (SR
Since T) was confirmed to eliminate animal cancer,
It is considered possible that these sick animals can carry on their original lives.

【図面の簡単な説明】[Brief description of drawings]

【図1】 走査型電子顕微鏡
(9000倍) 砂糖菓子のコンペイトウに似た形状をもつ、突起が激し
Figure 1: Scanning electron microscope
(9000 times) With a shape similar to the sugar confectionery's Konpeito, it has a lot of protrusions

【図2】 走査型電子顕微鏡
(18000倍)
FIG. 2 Scanning electron microscope
(18,000 times)

【図3】 透過型電子顕微鏡
(34000倍) 外殻は表面が不規則であり、電子密度が高い細胞壁がみ
られる
[Figure 3] Transmission electron microscope
(34000 times) The outer shell has an irregular surface, and cell walls with high electron density are seen.

【図4】 透過型電子顕微鏡
(60000倍) 細胞膜、細胞質、リボゾームがみられる
FIG. 4 Transmission electron microscope
(60000 times) Cell membrane, cytoplasm and ribosome are seen

【図5】 透過型電子顕微鏡
(12000倍) 核様体、細胞質がみられる
FIG. 5 Transmission electron microscope
(12000 times) nucleoid and cytoplasm are seen

【図6】 透過型電子顕微鏡
(40000倍) 細胞膜、細胞質、核様体、リボゾーム、ミトコンドリア
がみられる
FIG. 6 Transmission electron microscope
(40,000 times) Cell membrane, cytoplasm, nucleoid, ribosome, mitochondria are found

【図7】 培養細胞のHeLa細胞に対するSRT物質
の取込み
FIG. 7: Incorporation of SRT substance into cultured HeLa cells

【図8】 大腸癌細胞に対するSRT物質の取込みFIG. 8: Uptake of SRT substance into colon cancer cells

【図9】 培養細胞(HeLa)に対するSRTの行動
(18000倍)
FIG. 9: Behavior of SRT on cultured cells (HeLa) (18000 times)

【図10】 培養細胞(HeLa)の表面に対してSR
Tの着床(28000倍)
FIG. 10 SR for the surface of cultured cells (HeLa)
Implantation of T (28,000 times)

【図11】 培養細胞(HeLa)に対するSRTの着
床の拡大(42000倍)
FIG. 11: Expansion of implantation of SRT on cultured cells (HeLa) (42000 times)

【図12】培養細胞(HeLa)に対するSRTの侵入
行動(36000倍)
FIG. 12: Invasion behavior of SRT to cultured cells (HeLa) (36000 times)

【図13】 培養細胞(HeLa)に対するSRTの攻
撃(粘液を出す)(20000倍)
FIG. 13: Attack of SRT on cultured cells (HeLa) (excretion of mucus) (20,000 times)

【図14】 培養細胞(HeLa)に対するSRTの攻
撃(粘液を出す)(60000倍)
FIG. 14: Attack of SRT on cultured cells (HeLa) (excretion of mucus) (60000 times)

【図15】 培養細胞(HeLa)が破壊
(60000倍)
FIG. 15: Destruction of cultured cells (HeLa)
(60000 times)

【図16】 SRT物質の蛋白質成分の電気泳動FIG. 16: Electrophoresis of protein component of SRT substance

【図17】 動物癌(ウサギ大腿部)の計測FIG. 17: Measurement of animal cancer (rabbit thigh)

【図18】 動物癌(ウサギ大腿部)の体表面の剥離FIG. 18 Peeling of body surface of animal cancer (thigh of rabbit)

【図19】 動物癌の摘出FIG. 19: Removal of animal cancer

【図20】 摘出動物癌の表面層部分FIG. 20: Surface layer of excised animal cancer

【図21】 動物癌の内層部分FIG. 21: Inner layer of animal cancer

【図22】 動物癌のVx2の活性組織部分の摘出FIG. 22: Removal of active tissue part of Vx2 of animal cancer

【図23】 動物癌のホモジナイズ後の洗滌遠心の繰返FIG. 23: Repeated washing centrifugation after homogenization of animal cancer

【図24】 動物癌組織液FIG. 24 Animal cancer tissue fluid

【図25】 新しい動物(ウサギ)の大腿部への移植FIG. 25: Transplantation of new animal (rabbit) into thigh

【図26】 移植FIG. 26 Transplantation

【図27】 ウサギの解剖(大腿部と癌転の確認)[Fig. 27] Rabbit dissection (confirmation of thigh and cancerous transformation)

【図28】 ウサギ大腿部の癌に対するSRTによる空
洞化現象
FIG. 28: Cavitating phenomenon by SRT for cancer of rabbit thigh

【図29】 空洞化の侵攻Figure 29: Invasion of hollowing out

【図30】 動物癌(ウサギ大腿部)の消滅(8〜9割
程度)
FIG. 30: Disappearance of animal cancer (rabbit thigh) (about 80 to 90%)

【図31】 空洞化の現象 (2〜3割)[Fig. 31] Phenomenon of hollowing (20-30%)

【図32】 空洞化の現象 (6〜7割)FIG. 32: Phenomenon of hollowing (60 to 70%)

【図33】 動物癌(ウサギ大腿部)の縮小の現象(単
位cm) (1.7×2.5×2.0)
FIG. 33 Phenomenon of reduction of animal cancer (rabbit thigh) (unit: cm) (1.7 × 2.5 × 2.0)

【図34】 動物癌(ウサギ大腿部)の縮小の現象(単
位cm) (1.7×2.5×2.0)
FIG. 34 Phenomenon of reduction of animal cancer (thigh of rabbit) (unit: cm) (1.7 × 2.5 × 2.0)

【図35】 ウサギ大腿部癌組織部分の解剖FIG. 35: Dissection of rabbit femoral cancer tissue part

【図36】 ウサギ大腿部癌組織部分の解剖FIG. 36: Dissection of rabbit femoral cancer tissue part

【図37】 ウサギ大腿部癌組織に対するSRTの行動
の電子顕微鏡(40000倍)
FIG. 37: Electron microscope (40000 ×) of SRT behavior on rabbit femoral cancer tissue

【図38】 ウサギ大腿部癌組織に対するSRTの行動
の電子顕微鏡(26400倍)
FIG. 38: Electron microscope (26400 ×) of SRT behavior on rabbit femoral cancer tissue

【図39】 ウサギ大腿部癌組織に対するSRTの行動
の電子顕微鏡
FIG. 39: Electron microscopy of SRT behavior on rabbit femoral cancer tissue

【図40】 ウサギ大腿部癌組織に対するSRTの行動
の電子顕微鏡(30000倍)
FIG. 40: Electron microscope (30000 ×) of SRT behavior on rabbit femoral cancer tissue

【図41】 ウサギ大腿部癌組織に対するSRTの行動
の電子顕微鏡(48000倍)
FIG. 41: Electron microscope (48000 ×) of SRT behavior on rabbit femoral cancer tissue

【図42】 ウサギ大腿部癌組織に対するSRTの行動
の電子顕微鏡(36000倍)
FIG. 42: Electron microscope (36000 ×) of SRT behavior on rabbit femoral cancer tissue

【図43】 ウサギ大腿部癌組織に対するSRTの行動
の電子顕微鏡(48000倍)
FIG. 43: Electron microscope (48,000 ×) of SRT behavior on rabbit femoral cancer tissue

【図44】 ウサギ大腿部癌組織SRTによる破壊消滅
(40000倍)
FIG. 44: Destruction disappearance by rabbit femoral cancer tissue SRT (40,000 times)

【図45】 ウサギ大腿部癌組織に対するSRTの行動
の電子顕微鏡(28000倍)
FIG. 45: Electron microscope (28000 ×) of SRT behavior on rabbit femoral cancer tissue

─────────────────────────────────────────────────────
─────────────────────────────────────────────────── ───

【手続補正書】[Procedure amendment]

【提出日】平成7年7月3日[Submission date] July 3, 1995

【手続補正1】[Procedure Amendment 1]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】発明の名称[Name of item to be amended] Title of invention

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【発明の名称】 植物界に存在する物質(SRT)は生
命体の基本構造を有し、その特徴は動物癌(in vi
vo)や人癌(in vitro)を消滅させる。又そ
れ自体も自然崩壊して行く。
The substance existing in the plant kingdom (SRT) has a basic structure of living organisms, and its characteristic is animal cancer (in vi
vo) and human cancer (in vitro) are eliminated. In addition, it itself collapses naturally.

【手続補正2】[Procedure Amendment 2]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】図面の簡単な説明[Name of item to be corrected] Brief description of the drawing

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【図面の簡単な説明】[Brief description of drawings]

【図1】走査型電子顕微鏡
(9000倍) 砂糖菓子のコンペイトウに似た形状をもつ、突起が激し
Figure 1: Scanning electron microscope
(9000 times) With a shape similar to the sugar confectionery's Konpeito, it has a lot of protrusions

【図2】走査型電子顕微鏡
(18000倍)
FIG. 2 Scanning electron microscope
(18,000 times)

【図3】透過型電子顕微鏡
(34000倍) 外殻は表面が不規則であり、電子密度型が高い細胞壁が
みられる
[Figure 3] Transmission electron microscope
(34000 times) The outer shell has an irregular surface and cell walls with high electron density type are seen

【図4】透過型電子顕微鏡
(60000倍) 細胞膜、細胞質、リボゾームがみられる
[Figure 4] Transmission electron microscope
(60000 times) Cell membrane, cytoplasm and ribosome are seen

【図5】透過型電子顕微鏡
(12000倍) 核様体、細胞質がみられる
FIG. 5: Transmission electron microscope
(12000 times) nucleoid and cytoplasm are seen

【図6】透過型電子顕微鏡
(40000倍) 細胞膜、細胞質、核様体リボゾーム、ミトコンドリアが
みられる
FIG. 6 Transmission electron microscope
(40,000 times) Cell membrane, cytoplasm, nucleoid ribosome, mitochondria are found

【図7】HeLa細胞に対するSRT物質の取込み(光
学顕微鏡:in vitro)
FIG. 7: Uptake of SRT substance into HeLa cells (light microscope: in vitro)

【図8】大腸癌細胞に対するSRT物質の取込み(光学
顕微鏡:in vitro)
FIG. 8: Uptake of SRT substance into colon cancer cells (light microscope: in vitro)

【図9】培養細胞(HeLa)に対するSRTの行動
(18000倍)
FIG. 9: Behavior of SRT on cultured cells (HeLa)
(18,000 times)

【図10】培養細胞(HeLa)の表面に対してSRT
の着床(28000倍)
FIG. 10: SRT on the surface of cultured cells (HeLa)
Implantation (28,000 times)

【図11】培養細胞(HeLa)に対するSRTの着床
の拡大(42000倍)
FIG. 11: Expansion of implantation of SRT on cultured cells (HeLa) (42000 times)

【図12】培養細胞(HeLa)に対するSRTの侵入
行動(36000倍)
FIG. 12: Invasion behavior of SRT to cultured cells (HeLa) (36000 times)

【図13】培養細胞(HeLa)に対するSRTの攻撃
(粘液を出す) (2000倍)
[Fig. 13] Attack of SRT on cultured cells (HeLa) (emits mucus) (2000 times)

【図14】培養細胞(HeLa)に対するSRTの攻撃
(粘液を出す)(60000倍)
FIG. 14: Attack of SRT on cultured cells (HeLa) (to release mucus) (60000 times)

【図15】培養細胞(HeLa)が破壊される現象の電
子顕微鏡写真(60000倍)
FIG. 15: Electron micrograph (× 60000) of a phenomenon in which cultured cells (HeLa) are destroyed.

【図16】SRT物質の蛋白質成分の電気泳動の写真FIG. 16: Photograph of electrophoresis of protein component of SRT substance

【図17】動物癌(ウサギ大腿部)の計測FIG. 17: Measurement of animal cancer (rabbit thigh)

【図18】動物癌(ウサギ大腿部)の体表面の剥離FIG. 18: Detachment of body surface of animal cancer (thigh of rabbit)

【図19】動物癌の摘出FIG. 19: Removal of animal cancer

【図20】摘出動物癌の表面層部分FIG. 20: Surface layer portion of excised animal cancer

【図21】動物癌の内層部分FIG. 21: Inner layer of animal cancer

【図22】動物癌のVx2の活性組織部分の摘出FIG. 22: Removal of active tissue part of Vx2 of animal cancer

【図23】動物癌のホモジナイズ後の洗滌遠心の繰返FIG. 23: Repeated washing centrifugation after homogenization of animal cancer

【図24】動物癌組織液FIG. 24: Animal cancer tissue fluid

【図25】新しい動物(ウサギ)の大腿部への移植FIG. 25: Transplantation of new animal (rabbit) into thigh

【図26】ウサギの解剖(大腿部と癌組織部位の確認)FIG. 26: Rabbit dissection (confirmation of thigh and cancer tissue site)

【図27】ウサギ大腿部の癌に対するSRTによる空洞
化現象
FIG. 27: Cavitating phenomenon by SRT for cancer of rabbit thigh

【図28】動物癌(ウサギ大腿部)の消滅(8〜9割程
度)
FIG. 28: Disappearance of animal cancer (rabbit thigh) (about 80 to 90%)

【図29】空洞化の現象(2〜3割)FIG. 29: Phenomenon of hollowing (20-30%)

【図30】空洞化の現象(6〜7割)FIG. 30: Phenomenon of hollowing (60 to 70%)

【図31】動物癌(ウサギ大腿部)の縮小の現象(単位
cm) (1.7×2.5×2.0)
FIG. 31 Phenomenon of reduction of animal cancer (thigh of rabbit) (unit: cm) (1.7 × 2.5 × 2.0)

【図32】動物癌(ウサギ大腿部)の縮小の現象(単位
cm) (1.7×2.5×2.0)
FIG. 32: Phenomenon of reduction of animal cancer (rabbit thigh) (unit: cm) (1.7 × 2.5 × 2.0)

【図33】ウサギ大腿部癌組織部分の解剖FIG. 33: Dissection of rabbit femoral cancer tissue part

【図34】ウサギ大腿部癌組織部分の解剖FIG. 34: Dissection of rabbit femoral cancer tissue part

【図35】ウサギ大腿部癌組織に対するSRTの行動の
電子顕微鏡(40000倍)
FIG. 35: Electron microscope (40,000 ×) of SRT behavior on rabbit femoral cancer tissue

【図36】ウサギ大腿部癌組織に対するSRTの行動の
電子顕微鏡(26400倍)
FIG. 36: Electron microscope (26400 ×) of SRT behavior on rabbit femoral cancer tissue

【図37】ウサギ大腿部癌組織に対するSRTの行動の
電子顕微鏡
FIG. 37: Electron microscopy of SRT behavior on rabbit femoral cancer tissue

【図38】ウサギ大腿部癌組織に対するSRTの行動の
電子顕微鏡(30000倍)
FIG. 38: Electron microscope (30000 times) of SRT behavior on rabbit femoral cancer tissue

【図39】ウサギ大腿部癌組織に対するSRTの行動の
電子顕微鏡(48000倍)
FIG. 39: Electron microscope (48000 ×) of SRT behavior on rabbit femoral cancer tissue

【図40】ウサギ大腿部癌組織に対するSRTの行動の
電子顕微鏡(36000倍)
FIG. 40: Electron microscope (36000 ×) of SRT behavior on rabbit femoral cancer tissue

【図41】ウサギ大腿部癌組織に対するSRTの行動の
電子顕微鏡(48000倍)
FIG. 41: Electron microscope (48000 ×) of SRT behavior on rabbit femoral cancer tissue

【図42】ウサギ大腿部癌組織SRTによる破壊消滅
(40000倍)
FIG. 42: Destruction disappearance by rabbit femoral cancer tissue SRT
(40,000 times)

【図43】ウサギ大腿部癌組織に対するSRTの行動の
電子顕微鏡(28000倍)
FIG. 43: Electron microscope (28000 ×) of SRT behavior on rabbit femoral cancer tissue

【手続補正3】[Procedure 3]

【補正対象書類名】図面[Document name to be corrected] Drawing

【補正対象項目名】全図[Correction target item name] All drawings

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【図1】 FIG.

【図2】 [Fig. 2]

【図3】 [Figure 3]

【図4】 [Figure 4]

【図5】 [Figure 5]

【図6】 [Figure 6]

【図7】 [Figure 7]

【図8】 [Figure 8]

【図9】 [Figure 9]

【図10】 [Figure 10]

【図17】 FIG. 17

【図11】 FIG. 11

【図12】 [Fig. 12]

【図18】 FIG. 18

【図13】 [Fig. 13]

【図14】 FIG. 14

【図19】 FIG. 19

【図15】 FIG. 15

【図20】 FIG. 20

【図23】 FIG. 23

【図16】 FIG. 16

【図21】 FIG. 21

【図22】 FIG. 22

【図24】 FIG. 24

【図25】 FIG. 25

【図27】 FIG. 27

【図26】 FIG. 26

【図28】 FIG. 28

【図38】 FIG. 38

【図29】 FIG. 29

【図30】 FIG. 30

【図31】 FIG. 31

【図32】 FIG. 32

【図33】 FIG. 33

【図34】 FIG. 34

【図35】 FIG. 35

【図36】 FIG. 36

【図37】 FIG. 37

【図39】 FIG. 39

【図40】 FIG. 40

【図41】 FIG. 41

【図42】 FIG. 42

【図43】 FIG. 43

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】 物質(SRT)内に核様体体・ミトコ
ンドリア・リボゾーム等が確認され、又物質内の主なタ
ンパク質成分は6個存在し前出願の時に以外に4個確認
された。
1. Nucleoid bodies, mitochondria, ribosomes, etc. were confirmed in the substance (SRT), and there were 6 main protein components in the substance, and 4 were confirmed except when the previous application was filed.
【請求項2】 タンパク質成分の分子量は 第3番目 32.58kDa 第4番目 21.50
kDa第5番目 17.99kDa 第6番目 1
4.79kDaである。(但前回での第1番目は64.
47kDa第2番目は51.57kDa)
2. The molecular weight of the protein component is the third 32.58 kDa, the fourth 21.50.
5th kDa 17.99kDa 6th 1
It is 4.79 kDa. (However, the first one in the last time was 64.
47kDa second is 51.57kDa)
【請求項3】 試験管内実験で、人癌(HeLa細
胞、大腸癌細胞)ではSRTの投与後細胞内に侵入し細
胞を破壊し消滅させる。
3. In vitro tests, in human cancers (HeLa cells, colon cancer cells), enter SRT after administration of SRT and destroy and destroy the cells.
【請求項4】 動物生体内実験で、ウサギ大腿部に発
生した癌(Vx2由来)はSRTの接種(簡歇で10回
接種)後空洞化が生じ始め消滅して行く。
4. In vivo experiments in animals, the cancer (derived from Vx2) that has developed in the thigh of the rabbit begins to disappear after disappearing after inoculation of SRT (10 inoculations in brief).
JP7048931A 1995-02-01 1995-02-01 Substance (srt) existing in plant world has basic structure of life, its characteristic eliminates animal cancer (in vivo) and human cancer (in vitro) and it itself degrades naturally Pending JPH08208678A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7048931A JPH08208678A (en) 1995-02-01 1995-02-01 Substance (srt) existing in plant world has basic structure of life, its characteristic eliminates animal cancer (in vivo) and human cancer (in vitro) and it itself degrades naturally

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7048931A JPH08208678A (en) 1995-02-01 1995-02-01 Substance (srt) existing in plant world has basic structure of life, its characteristic eliminates animal cancer (in vivo) and human cancer (in vitro) and it itself degrades naturally

Publications (1)

Publication Number Publication Date
JPH08208678A true JPH08208678A (en) 1996-08-13

Family

ID=12817014

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7048931A Pending JPH08208678A (en) 1995-02-01 1995-02-01 Substance (srt) existing in plant world has basic structure of life, its characteristic eliminates animal cancer (in vivo) and human cancer (in vitro) and it itself degrades naturally

Country Status (1)

Country Link
JP (1) JPH08208678A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5473111A (en) * 1977-11-25 1979-06-12 Ikuo Suzuki Acrotine b
JPS54113414A (en) * 1978-02-25 1979-09-05 Ikuo Suzuki Acrotin b
JPS54113413A (en) * 1978-02-25 1979-09-05 Ikuo Suzuki Acrotin a

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5473111A (en) * 1977-11-25 1979-06-12 Ikuo Suzuki Acrotine b
JPS54113414A (en) * 1978-02-25 1979-09-05 Ikuo Suzuki Acrotin b
JPS54113413A (en) * 1978-02-25 1979-09-05 Ikuo Suzuki Acrotin a

Similar Documents

Publication Publication Date Title
de Amorin et al. Anthelmintic activity of the latex of Ficus species
CN103102407B (en) Genetic recombinant human-like collagen
Dobell et al. The intestinal protozoa of man
RU2438681C1 (en) Method of manufacturing dry powder of earthworms
Aufderheide Soft tissue taphonomy: a paleopathology perspective
Piearce et al. Fate of ciliates in the earthworm gut: An in vitro study
CN109182127A (en) The method that earthworm enteron aisle can cultivate antibiotic-resistant bacteria separation screening and identification
Sobirova et al. Extraction of “Elicitor” and determination of volatile organic substances contained in the elicitor
KR20010048219A (en) Process for manufacturing of bone graft materials using animal bones
CN104761629A (en) A broadspectrum efficient antimicrobial peptide Pb-CATH-OH1, a gene thereof, a preparing method of the peptide and applications of the peptide
JPH08208678A (en) Substance (srt) existing in plant world has basic structure of life, its characteristic eliminates animal cancer (in vivo) and human cancer (in vitro) and it itself degrades naturally
Tiwari et al. Antibacterial activity of bloom forming cyanobacteria against clinically isolated human pathogenic microbes
Góngora et al. Supplemented feed with biological silage of fish-processing wastes improved health parameters and weight gain of mice
CN101648992B (en) Small peptide B with antibacterial and antitumor functions and applications thereof
CN103054839A (en) Medicine for killing acid-fast staining positive (red) bacilli
Choyce et al. A system of surgery
CN101648993B (en) Small peptide A with antibacterial and antitumor functions and applications thereof
CN105061562A (en) Oliopeptide with anti-lung cancer effect and application of oliopeptide
Hemphill Development and applications of cestode and trematode laboratory models
CN105085623A (en) Oligopeptide and application thereof to preparation of anticancer bacterium inhibiting medicine
RU2401116C2 (en) Wound healing probiotic
Chaithong et al. In vitro development of Haplochis taichui (Trematoda: Heterophyidae)
TWI791918B (en) Use of mycelium of deinococcus spp. for manufacturing pharmaceutical composition for angiogenesis inhibition
CN101648990A (en) Small peptide D with antibacterial and antitumor functions and applications thereof
CN104342456A (en) Method for transfecting interfering RNA to echinococcus granulosus by virtue of electroporation